BUPIVACAINE AND EPI

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 for the supply of BUPIVACAINE AND EPI, identified by NSN 6505011277947, at a total price of $63.00 for two pounds or grams as defined by DLA standards. The award date was July 14, 2026, with a mandatory delivery date of July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms meaning the contractor assumes all transportation costs and risks until delivery. The unit price is $31.50 per unit with zero variance allowed in quantity, indicating strict compliance requirements. Packaging and labeling instructions are minimal; the shipment must be sent via the fastest traceable means with parcel post explicitly prohibited, and the only marking provided is the MARKFOR identifier W50YF252590478. No MIL-STD packaging, preservation, or labeling standards are cited, nor are any specific technical specifications or quality criteria referenced beyond conformance to contract terms. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, with invoicing required to comply with DFARS 252.232-7003. The contract administration is managed by Lisa Quinn, the Contracting Officer, and supported administratively by Shairy M. Cartagena of DLA Troop Support, Medical Supply Chain Pharmacy FSA. The procurement is conducted under a Firm Fixed Price structure with no options, extensions, or line-item flexibility. No contract clauses, representations, certifications, socioeconomic designations, or evaluation factors are documented within the award notice, suggesting a streamlined, low-dollar transaction typical of routine pharmaceutical supply under a blanket purchase agreement. The NAICS code 424210 applies, but no size status or small business certification is asserted. The absence of standardized FAR clauses, attachments, or detailed specifications indicates this is an administrative delivery order executed under pre-established procurement mechanisms with minimal documentation, relying on existing DLA supply chain protocols and regulatory compliance for execution.